Pathology Asia Holdings
VC Fund
Singapore, Singapore
Pathology Asia Holdings is a medical diagnostics company that is self-contained. According to Pathology Asia, it takes a doctor to know a doctor. As a result, both doctors and corporate professionals are in charge of our medical care. Their goal is to make quality diagnostic services available to people all around Southeast Asia and beyond.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Pathology Asia Holdings invests in
Stages Pathology Asia Holdings invests in
Countries Pathology Asia Holdings invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Christopher Ting
|
|||
Investment Focus
Industry
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Christopher Ting
Founder & CEO
|
Founder & CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ClearNote Health
|
ClearNote Health delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing. The company is actively conducting multiple clinical trials to explore the efficacy of their cancer detection methods, welcoming eligible participants. The company's approach relies on epigenomics, tracking gene activity todetect changes in cells indicative of cancer. | $70M / Series C / May 12, 2021 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Pathology Asia Holdings invest in?
Pathology Asia Holdings invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Pathology Asia Holdings?
Public channels for Pathology Asia Holdings include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pathology Asia Holdings?
The team at Pathology Asia Holdings includes Christopher Ting (Founder & CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
